Critical Outcome Technologies, Inc.

Ordinary Shares International Reporting
Verified Company Profile 5/02/2017
Contact Info
  • 700 Collip Circle
  • Suite 213
  • London, ONT N6G4X8
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jan 31, 2017 Interim Financial Report
CIK 0001585808
Fiscal Year End 4/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Canada
Year of Inc. 2008
Employees 10 a/o Mar 01, 2017
Company Officers/Contacts
Alison Silva CEO
Gene Francis Kelly CFO
Company Directors
John Drake Chairman, Independent Director, Audit Committee Member, Compensation Committee Member
Douglas Alexander Independent Director, Audit Committee Member, Nominating Committee Member
Dr. Bharatt Chowrira Independent Director
Bruno Maruzzo Independent Director, Audit Committee Member, Nominating Committee Member
David Sanderson Nominating Committee Member
Alison Silva Compensation Committee Member
John Yoo Independent Director, Compensation Committee Member, Nominating Committee Member
Service Providers
Accounting/Auditing Firm
140 Fullarton Street
Suite 1400
London, ONT, N6A 5P2
Securities Counsel
McMillan LLP
181 Bay Street
Suite 4400
Toronto, ONT, M5J 2T3
Investor Relations Firm
Stern IR, Inc.
19 West 87th Street
Suite 400
New York, NY, 5000
United States
COTQF Security Details
Share Structure
Market Value1 $21,732,384 a/o Jun 23, 2017
Authorized Shares Unlimited a/o Nov 22, 2016
Outstanding Shares 149,158,435 a/o Dec 19, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 136,486,325 a/o Jan 31, 2017
Par Value No Par Value
Shareholders of Record 2,185 a/o Oct 31, 2016
Non US Stock Exchange Listing
COT - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 31,081 (54.78%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security